Pathways’ Picks December 5: Year-End Policy Rush Begins

article image

December is starting off strong in the medtech policy space. Updates on an EU MDR grace period, the FDA commissioner nominee, India adverse event reporting, next-generation sequencing Medicare coverage, and more in our latest Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news.

An extended transition period written into the European Union Medical Device Regulation will be applicable to more devices, including many software products, under an amendment to the MDR approved by an EU Parliament committee this week. That, and more, in this week’s Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: